Correlation Between Viatris and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viatris and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Allogene Therapeutics, you can compare the effects of market volatilities on Viatris and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Allogene Therapeutics.
Diversification Opportunities for Viatris and Allogene Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viatris and Allogene is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Viatris i.e., Viatris and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Viatris and Allogene Therapeutics
Given the investment horizon of 90 days Viatris is expected to generate 0.57 times more return on investment than Allogene Therapeutics. However, Viatris is 1.75 times less risky than Allogene Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,189 in Viatris on August 31, 2024 and sell it today you would earn a total of 133.00 from holding Viatris or generate 11.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viatris vs. Allogene Therapeutics
Performance |
| Timeline |
| Viatris |
| Allogene Therapeutics |
Viatris and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viatris and Allogene Therapeutics
The main advantage of trading using opposite Viatris and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.The idea behind Viatris and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |